These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. Norrby-Teglund A; Haque KN; Hammarström L J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001 [TBL] [Abstract][Full Text] [Related]
6. Surviving Sepsis Campaign needed consensus to exclude selective decontamination of the digestive tract. Silvestri L; van Saene HK; de la Cal MA; Zandstra DF; Viviani M; Perić M; Gullo A Crit Care Med; 2008 Sep; 36(9):2716-7. PubMed ID: 18728507 [No Abstract] [Full Text] [Related]
7. Management of severe sepsis and septic shock: challenges and recommendations. Gullo A; Bianco N; Berlot G Crit Care Clin; 2006 Jul; 22(3):489-501, ix. PubMed ID: 16893735 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors in neonatal sepsis. O'Hare FM; William Watson R; Molloy EJ Acta Paediatr; 2013 Jun; 102(6):572-8. PubMed ID: 23419040 [TBL] [Abstract][Full Text] [Related]
9. Controversies in neonatal sepsis: immunomodulation in the treatment and prevention of neonatal sepsis. Moss SJ; Gennery AR Adv Exp Med Biol; 2006; 582():71-83. PubMed ID: 16802620 [No Abstract] [Full Text] [Related]
10. What's New in Shock, October 2020? Maegele M; Huang Q Shock; 2020 Oct; 54(4):413-415. PubMed ID: 32925708 [No Abstract] [Full Text] [Related]
11. What's new in Shock? December 2012. Clemens MG Shock; 2012 Dec; 38(6):575-6. PubMed ID: 23160519 [No Abstract] [Full Text] [Related]
12. Mirror, mirror on the wall, which is the fairest meta-analysis of all? Werdan K Crit Care Med; 2007 Dec; 35(12):2852-4. PubMed ID: 18043202 [No Abstract] [Full Text] [Related]
13. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock. Neugebauer EA Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203 [No Abstract] [Full Text] [Related]
14. What's New in Shock, July 2019? Hartwell JL; Zimmers TA Shock; 2019 Jul; 52(1):1-4. PubMed ID: 31188264 [No Abstract] [Full Text] [Related]
15. What is the pathophysiology of the septic host upon admission? Giamarellos-Bourboulis EJ Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S2-5. PubMed ID: 21129934 [TBL] [Abstract][Full Text] [Related]
16. [Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials]. Montravers P; Lasocki S; Seguin P; Malledant Y Ann Fr Anesth Reanim; 2007 Apr; 26(4):363-9. PubMed ID: 17336486 [TBL] [Abstract][Full Text] [Related]
17. Resuscitation in sepsis in 2016. What's new? Dr. Waleed Alhazzani in an interview with Dr. Roman Jaeschke: part 1. Alhazzani W; Jaeschke R Pol Arch Med Wewn; 2016 Oct; 126(10):794-795. PubMed ID: 27872455 [No Abstract] [Full Text] [Related]
18. Sepsis: pathogenesis, biomarkers, and treatment. Cheng B; Hoeft AH; Book M; Shu Q; Pastores SM Biomed Res Int; 2015; 2015():846935. PubMed ID: 25834828 [No Abstract] [Full Text] [Related]
19. What's new in Shock, October 2009? Weil BR; Meldrum DR Shock; 2009 Oct; 32(4):345-7. PubMed ID: 19752688 [No Abstract] [Full Text] [Related]
20. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches. Hazinski MF Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]